LABCORP HOLDINGS INC.·4

Feb 10, 3:13 PM ET

Schechter Adam H 4

4 · LABCORP HOLDINGS INC. · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Labcorp (LH) CEO Adam Schechter Receives 7,709 Shares via RSU Vesting

What Happened Adam H. Schechter, President & CEO (and Director) of Labcorp Holdings (LH), had Restricted Stock Units (RSUs) convert to common stock in early February 2026. He acquired a total of 7,709 shares through conversion/vesting (4,460 on Feb 6 and 3,249 on Feb 7). To satisfy tax withholding obligations, 2,667 shares were surrendered (stock withheld) on Feb 6 and Feb 9 — 1,315 shares at $277.20 ($364,518) and 1,352 shares at $274.01 ($370,462), totaling $734,980 withheld. Net effect: Schechter retained about 5,042 additional shares after withholding. The conversions show $0.00 exercise price (typical for RSU settlement).

Key Details

  • Transaction dates: Feb 6, 2026 (4,460 RSU conversions; 1,315 shares withheld at $277.20) and Feb 7, 2026 (3,249 RSU conversions; 1,352 shares withheld on Feb 9 at $274.01).
  • Withheld value: $364,518 + $370,462 = $734,980 (approx. $735K) paid via share withholding to cover taxes.
  • Net shares added: 7,709 acquired − 2,667 withheld = +5,042 net shares.
  • Footnotes: F1 = each RSU converts to one share; F2 = stock withholding for taxes; F3/F5 = vesting schedule details for the underlying grants; F4 = reflects aggregate RSUs held (aggregate number not specified here).
  • Filing: Form 4 filed Feb 10, 2026 covering Feb 6–9 transactions (no late filing indicated).
  • Remark: Exhibit 24 (Power of Attorney) included.

Context These transactions reflect RSU vesting and routine tax-withholding via share surrender (a common, non‑market-sale method of meeting tax obligations). The RSU conversions had no exercise price (not an options purchase); withheld shares were used for taxes rather than sold on the open market. Such vesting increases insider ownership but withholding is administrative and not a directional market signal.

Insider Transaction Report

Form 4
Period: 2026-02-06
Schechter Adam H
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-06+4,46092,034 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-06$277.20/sh1,315$364,51890,719 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-07+3,24993,968 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-09$274.01/sh1,352$370,46292,616 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F3][F4]
    2026-02-064,46018,679 total
    Common Stock (4,460 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F5][F4]
    2026-02-073,24915,430 total
    Common Stock (3,249 underlying)
Footnotes (5)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
  • [F2]Stock withholding to satisfy tax withholding obligations.
  • [F3]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
  • [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
  • [F5]The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Adam H. Schechter|2026-02-10

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY